Related Experiment Video
Updated: Sep 16, 2025

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
Effect of Apoptosis and Autophagy on Recombinant Protein Expression in Chinese Hamster Ovary Cells
Hui-Jie Zhang1,2,3, Qi Zhao1,2,3, Jumai Abiti1,2,3
1School of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, China.
Abstract:
Chinese hamster ovary (CHO) cells serve as a cornerstone platform for producing diverse therapeutic recombinant proteins, including monoclonal antibodies, vaccines, and hormones. Apoptosis and autophagy emerge as critical biological factors that directly impair cell proliferation and limit recombinant protein production. These cellular processes diminish CHO cell viability and reduce culture density, ultimately compromising protein yield and product quality. While apoptosis and autophagy exhibit distinct molecular mechanisms, they demonstrate functional interdependence in cellular regulation. This interrelationship highlights the importance of coordinated pathway modulation as an effective approach to improve both cell growth performance and recombinant protein synthesis. This review examines the complex interplay between apoptosis and autophagy pathways, their collective impact on recombinant protein expression, and contemporary strategies for developing stable anti-apoptotic/anti-autophagy cell lines. Through systematic analysis of these critical elements, we present optimized engineering approaches to enhance CHO cell culture systems and biopharmaceutical manufacturing processes, with the goal of facilitating more efficient therapeutic protein production. SUMMARY: Crosstalk mechanisms between apoptosis and autophagy in CHO cell cultures. Recent advances in real-time monitoring of apoptosis and autophagy. Strategic mitigation of apoptosis/autophagy to improve recombinant protein yields.
Insights
Understanding the interplay between apoptosis and autophagy in Chinese hamster ovary (CHO) cells is key. Modulating these processes can enhance cell proliferation and improve therapeutic protein production.
Area of Science:
- Biotechnology
- Cell Biology
- Biopharmaceutical Manufacturing
Background:
- Chinese hamster ovary (CHO) cells are vital for producing therapeutic proteins like monoclonal antibodies.
- Apoptosis and autophagy negatively impact CHO cell proliferation, viability, and recombinant protein yield.
- These cellular processes, though distinct, are functionally interdependent.
Purpose of the Study:
- To review the complex interplay between apoptosis and autophagy in CHO cells.
- To examine their collective impact on recombinant protein expression.
- To present strategies for developing stable anti-apoptotic/anti-autophagy cell lines for enhanced biomanufacturing.
Main Methods:
- Systematic analysis of apoptosis and autophagy pathways in CHO cells.
- Review of contemporary strategies for engineering cell lines.
- Examination of real-time monitoring techniques for these cellular processes.
Main Results:
- Apoptosis and autophagy crosstalk significantly affects CHO cell performance.
- Coordinated modulation of these pathways offers a promising approach to improve cell growth and protein synthesis.
- Engineering stable cell lines can mitigate negative impacts on protein yield and quality.
Conclusions:
- Targeting the interplay between apoptosis and autophagy is crucial for optimizing CHO cell-based bioproduction.
- Developing strategies to mitigate these processes enhances both cell growth and therapeutic protein yields.
- This review provides insights into optimized engineering approaches for efficient biopharmaceutical manufacturing.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

